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Objective: To address the utility of the forced oscillation technique (FOT) in assessing
bronchodilator responsiveness compared with forced expiratory volume in 1 s (FEV1).
Methods: This is a retrospective analysis of consecutive 126 patients with a clinical history
of asthma without any other lung diseases at a pulmonary function testing laboratory. The
following measurements were obtained three times each, before and after two doses of
pirbuterol 0.2mg inhalation: the respiratory resistance at 5Hz (Rrs5), the mean
respiratory resistance between 5 and 20Hz (Rrs5–20), and the mean respiratory
conductance (Grs5–20) by FOT and the FEV1 by spirometer. These measurements were
transformed into dimensionless subject-specific effect-size ‘‘d-scores’’ by dividing them by
the estimated pooled within-subject standard deviation.
Results: Descriptive statistics for each value were the following [mean baseline value
(7SD), D value (pre- minus post value), and d-score (P value compared to FEV1)]: Grs5–20
(L s1 kPa1) [1.7970.53, D ¼ +0.39, d ¼ 2.64 (Po0.001)], Rrs5–20 (kPa L1 s)
[0.6070.16L, D ¼ 0.10, d ¼ 2.56 (P ¼ 0.001)], Rrs5 (kPa L1 s) [0.7870.25,Elsevier Ltd. All rights reserved.
try technique; IOS, impulse oscillometry system; Rrs5 and Rrs20, the respiratory resistance at 5 and
s5–20, the mean respiratory resistance between 5 and 20Hz, Rrs; Grs5–20, the total respiratory
0, Grs; FEV1, forced expiratory volume in 1 s; PEF, peak expiratory flow; GEE analysis, generalized
hronic obstructive pulmonary disease; ATS, American Thoracic Society; ERS, European Respiratory
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M. Yaegashi et al.996D ¼ 0.16, d ¼ 2.52 (Po0.001)], and FEV1 (L) [1.9070.64, D ¼ 0.20, d ¼ 1.83]. The
higher d-score of Grs5–20, Rrs5–20 and Rrs5 compared to FEV1 indicates that these are
better indicators for bronchodilator response than FEV1. The percentages of subjects
exhibiting change in the expected direction after bronchodilator were not significantly
different between each value: Rrs5 (85.7%), Rrs5–20 (83.3%), Grs5–20 (83.3%), and FEV1
(83.3%) [P40.05].
Conclusions: Several forced oscillation measures, namely Grs5–20, Rrs5–20 and Rrs5, are
more accurate and sensitive for detecting bronchodilator response than FEV1 in patients
with asthma.
& 2006 Elsevier Ltd. All rights reserved.Background
Measuring reversibility of airway obstruction by spirometry
is important diagnostic information in the diagnosis and
management of asthma. However, compared to spirometric
measurements to determine bronchodilator responsiveness
such as forced expiratory flow in 1 s (FEV1) or peak
expiratory flow (PEF), forced oscillometry technique (FOT)
measurement is easier for patients to perform and requires
less patient cooperation. Previous studies, though, showed
mixed results in the use of FOT to evaluate asthma. Van
Noord and coworkers1 showed that one of the FOT
measurements, Rrs6 was less sensitive than Raw in their
study in asthma and chronic obstructive pulmonary
disease (COPD) patients. On the other hand, in Zerah and
coworker’s study which used better defined patients,2 the
respiratory conductance (Grs0) was as sensitive and specific
as FEV1. Thus, the guideline for FOT published by the
European Respiratory Society Task Force3 called for a study
in a larger, well-defined group. In response to that need, we
conducted this study using different statistical and pulmon-
ary function methodologies in a larger number of patients
with asthma.Methods
Patients
We retrospectively collected data of outpatients who had
both spirometry and forced oscillation technique pre- and
post-bronchodilator (pirbuterol) at the Kings County Hospi-
tal between 2000 and 2003. We included patients with any
obstructive pattern in PFT independent of bronchodilator
response and a clinical history of asthma. Patients with
equivocal clinical history were included only when they met
the criteria for bronchodilator response defined by FEV1
increase more than 12% and 200 cc.4 Patients with known
COPD, more than 10 pack-year history of smoking or
obstructive pattern without a clinical history of asthma
were excluded. We excluded patients with known lung
disease other than asthma. All patients where their
spirometry quality did not meet the American Thoracic
Society (ATS) criteria for spirometery4 or who were missing
FOT data were excluded. All patients were outpatients and
clinically stable at the time of the measurement.Study design
The pulmonary function test procedure was as follows: Pre-
bronchodilator measurement of spirometry and FOT were
obtained first. FEV1, PEF, obstructive/restrictive pattern,
and quality of the study were recorded from the spirometry.
Among the FOT measurements, the respiratory resistance at
5Hz (Rrs5) and at 20Hz (Rrs20), R5minus R20 (Rrs5–Rrs20),
the mean respiratory resistance (Rrs5–20: the mean resis-
tance from Rrs5 to Rrs20) in kPa L1 s, and the mean
respiratory conductance (Grs5–20: the reciprocal of
Rrs5–20) in L s1 kPa1 were recorded. Then, two puffs of
pirbuterol 0.2mg inhalation were given via a metered dose
inhaler. After 30min, the spirometric and FOT measure-
ments were repeated. All measurements followed technical
recommendations from ATS and European Respiratory
Society (ERS).3–5
Spirometry measurement including FEV1 and PEF were
recorded at the mouth using a pneumotachograph with
electronic integration. Highest values of three maneuvers
were reported for pre- and post-bronchodilator measure-
ments.
The FOT measurements were obtained using a method of
FOT (IOS; impulse oscillometry system: Jaeger; Wurzburg,
Germany6) using previously described methodology by
Landser.7,8 Briefly, a random noise signal of 5 to 35Hz was
generated by loudspeakers and superimposed on the
spontaneous breathing of the subject wearing a mouthpiece
and a nose-clip. The subject’s cheeks were held firmly by
him/herself while measurements were obtained in a sitting
position with the head in a neutral position. A continuous
measurement of 60 s was obtained and divided into first,
second and third 20 s periods. Rrs5, Rrs20, Rrs5–Rrs20,
Rrs5–20, and Grs5–20 were obtained for each time period
pre- and post-bronchodilator, which totaled three measure-
ment values of each parameter for pre and three measure-
ment values for post-bronchodilator. The mean respiratory
resistance (Rrs5–20) was calculated from R5, R10, R15 and
R20. The mean value of respiratory conductance (Grs5–20)
was calculated as the reciprocal of Rrs5–20.Statistical analysis
For each measurement, a change score ðD ¼ X¯D  X¯BÞ was
computed as the difference between post-drug (D) and
baseline (B) means. Since various spirometric and FOT
measurements have differing metrics, direct numerical
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Table 1 Anthropometric data and baseline spirometry
results.
(Total of 126 subjects)
Sex
Women 96 (76.1%)
Men 30 (23.8%)
Age 45.1713.9 year-old
Height 16478.0 cm
Weight 83.9720.1 kg
BMI 31.377.5 kg/m2
Race
Black 103 (81.7%)
Hispanic 19 (15.1%)
Asian 3 (2.4%)
White 1 (0.8%)
Smoking history
Never 108
Quit 18 (average 4.39 pack-year)
Symptoms 95 patients answered
Dyspnea 48 (50.5%)
Cough 35 (36.8%)
Sputum 17 (17.9%)
Wheezing 11 (11.6%)
Symptomatic 58 (61.1%)
Asymptomatic 37 (38.9%)
FVC (pre-bronchodilator) 2.7770.85 L
FVC % predicted (pre) 88.7718.0%
FOT for BD responsiveness in asthma 997comparisons of these scores are statistically questionable.
They were therefore transformed into dimensionless sub-
ject-specific effect-size scores (d-score) by dividing them by
the estimated pooled (across D and B) within-subject
standard deviation (d ¼ D=s ¼ D=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðs2B þ s2DÞ=2
q
; when all
three pre- and post-value are present), where sB and sD
represent estimated pooled (across subjects) within-subject
standard deviations. Modified equations were used when
subjects had one repeat data point missing (i.e. two
measurements instead of three repeated measurements).
These d-score correspond to Cohen’s ds estimate of effect
size for the difference between two means.9 The sign of
these scores was reversed for Rrs5–20, Rrs5, Rrs20 and
Rrs5–Rrs20, since the expected direction of the effect of the
bronchodilator is opposite for these measures. Mixed linear
models were employed to estimate sB, and sD. A further
mixed linear model was then used to detect differences in
mean effect among the seven measures: their covariance
matrix was assumed to be unstructured, and Satterthwaite
adjustments to degrees of freedom were applied. Both
unadjusted and Tukey-adjusted P values for post hoc tests of
pair-wise differences are reported.
Analysis was also conducted on the signs of the d-scores,
to determine what proportion of subjects exhibited change
in the expected direction. A generalized estimating equa-
tions (GEE) analysis was conducted to test for differences
in this population among the seven measures. Unadjusted
P-values for post-hoc tests of pair-wise differences were
used. For all comparisons, P-values less than 0.05 were
considered significant. SAS (SAS Institute, Cary, NC) software
was used for analysis.FEV1 1.9070.64 L
FEV1% predicted 77.7719.8%
FFV1/FVC ratio 70.4711.9Results
Anthropometric data in the 126 patients included in the
study are presented in Table 1. Of the possible total of 5292
data points (126 subjects seven measures two conditions
[pre+post]  three replications), only 25 data points
(belonging to eight subjects) were missing, and at least
one replication was always available. An omnibus test of
differences in mean effect size among the seven measures
yielded F(6,119) ¼ 22.39, Po0.0001.
Descriptive statistics for mean raw scores, D-scores and d-
scores are presented in Table 2. The higher d-score of
Grs5–20, Rrs5–20 and Rrs5 indicates that these are better
indicators for bronchodilator response than FEV1. Looking at
other indexes, the pattern of unadjusted P values o0.05
suggests there are three homogeneous sets of measures in
descending order of sensitivity; {Grs5–20, Rrs5–20 and Rrs5},
{FEV1, Rrs20} and {Rrs5–Rrs20, PEF}. Post-hoc tests indicated
that PEF and Rrs5–Rrs20 are less sensitive for bronchodilator
response than any of the other measurements [Tukey
Po0.0001 in all cases]; in addition, Rrs20 is less sensitive
than either Grs5–20 or Rrs5–20 [Tukey Po0.01 in both
cases].
Table 3 shows the proportions of subjects exhibiting
change in the expected direction. A GEE test of differences
among the seven measures yielded w2 ¼ 21.95, df ¼ 6,
P ¼ 0.001. Post-hoc comparisons indicate that Rrs5–Rrs20
& PEF are less likely to show change in the expecteddirection than any other measure (Po0.05 in all cases,
except for Rrs20 vs. PEF, P ¼ 0.14). On the other hand, the
percentage of subjects exhibiting change in the expected
direction after bronchodilator was not significantly different
between each value: Rrs5 (85.7%), Rrs5–20 (83.3%), Grs5–20
(83.3%), and FEV1 (83.3%) [P40.05].
In each measurement, the corresponding changes to 0.2L
increase in FEV1 were presented in Table 4. DFEV1 of 0.2L (or
10.5% change) corresponded to a d-score of 1.85. This
change was equivalent to DGrs5–20: +0.28 (+15.6%),
DRrs5–20: 0.075 (16.0%), and DRrs5: 0.125 (12.5%).
The percentages of subjects showing this change were 62%
in Rrs5–20, 61% in Rrs5, 60% in Grs5–20, 58% in Rrs20, and
45% in FEV1. According to the unadjusted P-value o0.05,
measurements can be classified into three groups in
descending order of sensitivity for bronchodilator respon-
siveness: {Grs5–20, Rrs5–20, Rrs5, Rrs20}, {FEV1}, and
{Rrs5–Rrs20, PEF}.Discussion
The sensitivity of FOT measurement compared with that of
spirometry and the correlation between their indices in
bronchodilation testing were previously undetermined and
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response in a large well-defined group of asthma patients
using different spirometry and FOT measures. In order to
select patients with asthma without including patients
with COPD, patients with smoking history more than 10-
pack years were excluded from the study. This enabled us toTable 3 Number (%) of subjects showing d-score change in the
Measure (n ¼ 126)
Rrs5 Rrs5–20 Grs5–20
Number of subjects with
any BD response
108 105 105
(percentage) (85.7) (83.3) (83.3)
BD: bronchodilator.
Table 2 Descriptive statistics for FOT measurements
and FEV1 before and after pirbuterol.
Measure Variable Mean SD P value
(vs. FEV1)
Grs5–20 Baseline 1.79 0.53
(L s1 kPa1) Post-drug 2.18 0.65 0.0063
D 0.39 0.43
d-score 2.64 2.9
Rrs5–20 Baseline 0.6 0.16
(kPa L1 s) Post-drug 0.5 0.14 0.010
D 0.1 0.11
d-score 2.56 2.66
Rrs5 Baseline 0.78 0.25
(kPa L1 s) Post-drug 0.62 0.2 0.0095
D 0.16 0.16
d-score 2.52 2.44
Rrs20 Baseline 0.5 0.12
(kPa L1 s) Post-drug 0.44 0.12 0.34
D 0.06 0.08
d-score 2.09 2.75
FEV1 Baseline 1.9 0.64
(L) Post-drug 2.1 0.68 N/A
D 0.2 0.25
d-score 1.83 2.27
Rrs5–Rrs20 Baseline 0.23 0.13
(kPa L1 s) Post-drug 0.17 0.1 0.0001
D 0.06 0.11 (FEV1 better)
d-score 0.8 1.45
PEF Baseline 4.16 1.43
Post-drug 4.55 1.53 0.0001
D 0.39 0.86 (FEV1 better)
d-score 0.75 1.65
Those P values for each measurement are unadjusted P
values comparing d-scores to that of FEV1 (shown in bold).study a more homogeneous asthmatic patient group than
previous studies.
In general, the simplest way to evaluate a new technique
is to compare it with a ‘‘gold standard.’’ Although a FEV1
increase X200 cc and X12% is considered as a ‘significant
bronchodilator response’, this could not be used as a gold
standard, since this is a highly insensitive test to diagnose
asthma.10,11 In order to compare the FOT with spirometry,
we performed a statistical analysis using a d-score.9 The d-
score is defined as the change (between baseline and post-
bronchodilator) divided by the estimated pooled within
subject standard deviation. Larger d-score means a higher
signal-to-noise ratio. This enabled us to compare the
changes after bronchodilator with each different spiro-
metric and FOT measurement, since each measurement has
different metrics. To compare the d-score in different
measurements, both unadjusted and Tukey-adjusted
P-values were reported. Since several measures are known
to be more sensitive than others to detect bronchodilator
response (i.e. FEV1 vs. PEF), using unadjusted P-values
would be statistically appropriate.
This study showed {Grs5–20, Rrs5–20 and Rrs5} are more
sensitive than {FEV1, Rrs20}, which are more sensitive than
{Rrs5–Rrs20, PEF}. In patients with asthma, Rrs is increased
at lower frequencies and falls with increasing frequencies
(negative frequency dependence).12 In addition, FOT has
been shown to be more sensitive in disclosing upper airway
stenosis by detecting at the increased Rrs at lower
frequencies.13 It is not clear whether the change in Rrs
reflects reversibility in central or peripheral airways.
Although Mead’s two-compartment model assumes that the
negative frequency dependence can be explained by
increase in peripheral airway resistance,6,7 the evidence
supporting its use is poor. In addition, the negative
frequency dependence is not specific and seen in other
conditions including ankylosing spondylitis and kyphoscolio-
sis.14 Volume measurement like FEV1 had higher sensitivity
when its absolute values were compared rather than
relative change after bronchodilator in a previous study. In
the study, volume measurements demonstrated better
reproducibility than those of maximal flows and resistance.1
However, in our study FOT measures had a higher sensitivity
than FEV1 for detecting bronchodilator response in asth-
matics even compared in absolute values.
The second important finding of our study was that the
percentages of subjects exhibiting change in the expected
direction after bronchodilator were not different between
each measurement except for Rrs5–Rrs20 and PEF. This type
of analysis overestimates bronchodilator response in bothexpected direction for each measure.
Rrs20 FEV1 Rrs5–Rrs20 PEF
101 105 89 91
(80.2) (83.3) (70.6) (72.2)
ARTICLE IN PRESS
Table 4 Number (%) of subjects showing change in each measurement equivalent or more than 0.2 L FEV1 increase (d-score
X1.85).
n ¼ 126 Measure
Rrs5 Rrs5–20 Grs5–20 Rrs20 FEV1 Rrs5–Rrs20 PEF
D value when d ¼ 1.85 0.125 0.075 0.28 0.054 0.2 0.14 0.95
(%changes from baseline) (16.0%) (12.5%) (15.6%) (10.8%) (10.5%) (60.9%) (22.8%)
Number (%) of 77 78 76 73 57 27 27
patients who showed
equivalent changes to
0.2 L increase in FEV1
(61.1%) (61.9%) (60.3%) (57.9%) (45.2%) (21.4%) (21.4%)
P-value (vs. FEV1) 0.0049
 0.0041 0.013 0.038 N/A o0.0001y o0.0001y
Rrs5, Rrs5–20, Grs5–20, and Rrs20 detected more patients with bronchodilator response than FEV1.
yFEV1 detected more patients with bronchodilator response than Rrs5–Rrs20 or PEF.
FOT for BD responsiveness in asthma 999spirometry and FOT, since any small change from baseline is
counted as a positive bronchodilator response.4 Of note,
though, the percentage of patients who showed changes
more than the threshold value was similar between FEV1 and
FOT indexes including Grs5–20, Rrs5–20 and Rrs5. The
threshold values for bronchodilator response of FOT mea-
sures, which we found were smaller in our study compared
to previous studies.
There are some discrepancies between this study and the
previous study by Van Noord et al.1 Although both studies
showed that airway resistance at lower frequency (Rrs5 or
Rrs6) is more sensitive than FEV1 in absolute changes, our
study showed a much lower threshold change for Rrs5
compared to their study (16% vs. 35.6%). This discrepancy
resulted in an increased percentage of patients who had
more than the threshold bronchodilator response (61% vs.
16%) in our study compared to their study. As noted above,
we used a different statistical analysis (d-score) from the
study by Van Noord and coworkers. This enabled direct
comparison of all the different types of measurements
through quasi-ANOVA analyses. In addition, this statistical
significance testing incorporates the difference of two
sample means to compute the d-score, whereas the
coefficient of variance used by Van Noord et al. does not.
Looking at the patient population, the previous study
evaluated mixed patient population with asthma and COPD,
compared to this study where we used only uniform patients
with asthma. Van Noord’s group published another article
showing that even patients with similar FEV1, the Rrs varies
depending on the diagnosis of the patients. For example,
the Rrs was highest in asthmatics compared to patients with
emphysema and chronic bronchitis.12 Those reasons may
have accounted for the difference between this study and
Van Noord’s study.
Zerah et al.2 evaluated reversibility of airway obstruction
in two well-defined groups of patients with asthma and
COPD. In that study, FEV1 and Grs0 both exhibited compar-
able changes with similar sensitivity and specificity in
detecting bronchodilator responsiveness in asthmatics and
COPD patients. The current study is not a simple duplicate of
the study with larger number of asthma patients. We
evaluated Grs5–20 that is the reciprocal of mean Rrs at5-20Hz, not Grs0 that is the reciprocal of estimated Rrs at
0 Hz. Thus, those studies are complimentary to each other.
There are limitations to this study. First, this is a
retrospective analysis of PFT and FOT, thus all the inherent
problems associated with the retrospective study design is
applicable. Our results would now have to be validated
prospectively. Second, the three measurements (Grs5–20,
Rrs5–20 and Rrs5) were obtained without the patient
removing his/her mouth from the mouthpiece. This could
result in overestimation of d-score in FOT measures. The
intra-subject variation of the FOT measures in patients with
or without obstruction are reported with coefficients of
variation between 10 to 15.2.1,15,16 Thus, the manufacturer
of the specific IOS is not recommending repeating measure-
ments. Third, upper airway shunt artifacts could under-
estimate the upper airway resistance measurements. To
minimize this artifact, all subject held their cheek to reduce
the shunt in our study.17,18 Nonetheless this artifact is
particularly documented in patients with airway obstruc-
tion. Use of head generator has been suggested to reduce
the artifacts.19 In a comparative study by Iwatsubo et al.20
they found that the standard method of applying forced
oscillation at the mouth seems an acceptable method for
measuring respiratory impedance compared to the head
generator method. Lastly, coherence functions were not
used in our study unlike in other previous studies21 because
they were not saved in the PFT database. On the other hand,
in the ERS guideline for FOT standardization, the coefficient
of variation is optionally recommended as the main index to
the use for the reliability and repeatability of airway
impedance data.3 The coefficient of variation is useful for
comparing scatter of variables, since that is defined as
standard of deviation divided by mean. To compensate for
this, we used the d-score, which incorporates the pre- and
post-standard deviation and mean value into the equation in
our study. This is an equally statistically acceptable or
possibly even better alternative than the coefficient of
variation cited by ERS.
In conclusion, we found that several forced oscillation
measures, namely Grs5–20, Rrs5–20 and Rrs5, are more
specific for detecting bronchodilator response in patients
with asthma than FEV1. These measurements are also
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M. Yaegashi et al.1000equally sensitive to FEV1. Since measurement of forced
oscillation is an easier technique for patients to perform,
FOT may be useful to detect bronchodilator response in
asthmatic patients. Future research should test our findings
in a prospective fashion.
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